Orens D K, Kester L, Fergus L C, Stoller J K
Cleveland Clinic Foundation, OH.
Respir Care. 1991 Oct;36(10):1099-114.
To assess the cost impact of using metered dose inhalers (MDIs) versus small volume nebulizers (SVNs) for hospitalized adult patients not being managed in ICUs, we analyzed the labor, equipment, and medication costs associated with using MDIs at The Cleveland Clinic Foundation. Over the study interval (January 1988-December 1989), a policy was implemented to enhance MDI use, resulting in increased use of MDIs (18% of all bronchodilator treatments in 1989 vs 5% in 1988). Based on a volume of approximately 70,000 bronchodilator treatments/year in our hospital, increased MDI use with this policy reduced direct costs by $26,510, with associated savings in respiratory-therapist time. To extend this analysis of costs to other institutional settings, we present an analysis of projected changes in institutional costs when the volume of bronchodilator therapies and the percentage administered by MDI varies.
为评估在非重症监护病房住院的成年患者中使用定量吸入器（MDI）与小容量雾化器（SVN）的成本影响，我们分析了克利夫兰诊所基金会使用MDI相关的人工、设备和药物成本。在研究期间（1988年1月至1989年12月），实施了一项增加MDI使用的政策，导致MDI的使用量增加（1989年占所有支气管扩张剂治疗的18%，而1988年为5%）。基于我院每年约70000次支气管扩张剂治疗的数量，该政策增加MDI的使用使直接成本降低了26510美元，同时节省了呼吸治疗师的时间。为将这一成本分析扩展到其他机构环境，我们分析了当支气管扩张剂治疗量和MDI给药百分比变化时机构成本的预计变化。
